Abstract
RNA interference (RNAi) is the process of sequence-specific, posttranscriptional gene silencing in animals and plants initiated by double-stranded (ds) RNA that is homologous to the silenced gene1,2,3,4,5,6,7. This technology has usually involved injection or transfection of dsRNA in model nonvertebrate organisms. The longer dsRNAs are processed into short (19–25 nucleotides) small interfering RNAs (siRNAs) by a ribonucleotide–protein complex that includes an RNAse III–related nuclease (Dicer)7, a helicase family member8, and possibly a kinase9 and an RNA-dependent RNA polymerase (RdRP)10,11. In mammalian cells it is known that dsRNA 30 base pairs or longer can trigger interferon responses that are intrinsically sequence-nonspecific12, thus limiting the application of RNAi as an experimental and therapeutic agent. Duplexes of 21-nucleotide siRNAs with short 3′ overhangs, however, can mediate RNAi in a sequence-specific manner in cultured mammalian cells12,13. One limitation in the use of siRNA as a therapeutic reagent in vertebrate cells is that short, highly defined RNAs need to be delivered to target cells—a feat thus far only accomplished by the use of synthetic, duplex RNAs delivered exogenously to cells12,13. In this report, we describe a mammalian Pol III promoter system capable of expressing functional double-stranded siRNAs following transfection into human cells. In the case of the 293 cells cotransfected with the HIV-1 pNL4-3 proviral DNA and the siRNA-producing constructs, we were able to achieve up to 4 logs of inhibition of expression from the HIV-1 DNA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Hammond, S.M., Bernstein, E., Beach, D. & Hannon, G.J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293–296 (2000).
Fire, A. RNA-triggered gene silencing. Trends Genet. 15, 358–363 (1999).
Svoboda, P., Stein, P., Hayashi, H. & Schultz, R.M. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 127, 4147–4156 (2000).
Sharp, P.A. RNA interference—2001. Genes Dev. 15, 485–490 (2001).
Clemens, J.C. et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl. Acad. Sci. USA 97, 6499–6503 (2000).
Elbashir, S.M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188–200 (2001).
Bernstein, E., Caudy, A.A., Hammond, S.M. & Hannon, G.J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001).
Dalmay, T., Horsefield, R., Braunstein, T.H. & Baulcombe, D.C. SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis. EMBO J. 20, 2069–2078 (2001).
Nykanen, A., Haley, B. & Zamore, P.D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309–321 (2001).
Lipardi, C., Wei, Q. & Paterson, B.M. RNAi as random degradative PCR. siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell 107, 297–307 (2001).
Smardon, A. et al. EGO-1 is related to RNA-directed RNA polymerase and functions in germ-line development and RNA interference in C. elegans. Curr. Biol. 10, 169–178 (2000).
Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742–9747 (2001).
Bertrand, E. et al. The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA 3, 75–88 (1997).
Good, P.D. et al. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther. 4, 45–54 (1997).
Scherr, M. & Rossi, J.J. Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts. Nucleic Acids Res. 26, 5079–5085 (1998).
Scherr, M. et al. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA. Mol. Ther. 4, 454–460 (2001).
Sijen, T. et al. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107, 465–476 (2001).
Lee, N.S. et al. Functional colocalization of ribozymes and target mRNAs in Drosophila oocytes. FASEB. J. 15, 2390–2400 (2001).
Acknowledgements
We thank Aaron Coleman for providing pIND and G. Pavlakis and A. Michienzi for the CMV-rev-EGFP vector. The authors also wish to thank Alessandra Poggi for help with some preliminary experiments. This research was supported by grants from the National Institutes of Health AI 29329, AI42552 and AI 46030.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have filed a patent application covering the technology described in this manuscript. The patent, if issued, would be owned by the Beckman Research Institute of the City of Hope, a not-for-profit organization.
Rights and permissions
About this article
Cite this article
Lee, N., Dohjima, T., Bauer, G. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20, 500–505 (2002). https://doi.org/10.1038/nbt0502-500
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0502-500
This article is cited by
-
Therapeutic siRNA: State-of-the-Art and Future Perspectives
BioDrugs (2022)
-
A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition
Drug Delivery and Translational Research (2022)
-
Editing out HIV: application of gene editing technology to achieve functional cure
Retrovirology (2021)
-
shRNA transgenic swine display resistance to infection with the foot-and-mouth disease virus
Scientific Reports (2021)
-
In Vivo Gene Silencing of Potato Virus X by Small Interference RNAs in Transgenic Potato
Potato Research (2020)